Today the House Energy and Commerce Subcommittee on Health is considering a series of bills that would stabilize and strengthen the health insurance market and decrease the number of uninsured by improving the ability of people with pre-existing conditions to obtain and afford comprehensive health coverage.
Washington, D.C.
Washington, D.C. – March 27, 2019 – A proposed rule issued by the U.S. Food and Drug Administration (FDA) today would modernize mammography quality standards and address breast density reporting to patients and their health care providers.
ACS CAN is concerned about a recent administration announcement affirming a district court decision to overturn the health care law.
Washington, D.C. – The U.S.
Washington, D.C. – The White House has announced its intention to appoint Dr. Ned Sharpless, current director of the National Cancer Institute (NCI), as acting commissioner of the Food and Drug Administration (FDA). Dr.
The administration released its FY20 budget today including a $4.7 billion cut for medical research at the National Institutes of Health (NIH) including a nearly $900 million cut for the National Cancer Institute (NCI).
Washington, D.C. – March 6, 2019 – Bipartisan legislation introduced today in the U.S. Senate and House of Representatives would ensure that surprise out-of-pocket expenses are not a barrier to lifesaving colorectal cancer screenings for seniors on Medicare.
WASHINGTON, D.C. – In a major victory for the nation’s health and the fight against tobacco, a federal court on Tuesday ordered the U.S. Food and Drug Administration (FDA) to issue a final rule mandating graphic health warnings on cigarette packs and advertising by March 15, 2020.
Washington, D.C. – Following is a statement from Lisa Lacasse, president of the American Cancer Society Cancer Action Network (ACS CAN), responding to reports that Food and Drug Administration (FDA) Commissioner Scott Gottlieb is resigning: